Lancet Citizens’ Commission on Reimagining India’s Health System Public Webinar Series, in collaboration with Lancet COVID-19 Commission India Task Force
Panelists:
Gagandeep Kang, Professor of Microbiology, Department of Gastrointestinal Sciences, Christian Medical College
Peter Piot, Director and Handa Professor of Global Health, London School of Hygiene and Tropical Medicine
Gautam Menon, Professor of Physics and Biology, Ashoka University
K. Sujatha Rao, Former Secretary of Health and Family Welfare, Government of India
K Srinath Reddy, President, Public Health Foundation of India
Moderator:
Sarah Jacob, Editor/Anchor of ‘We The People’ on NDTV
Description:
The Lancet Citizens’ Commission on Reimagining India’s Health System is an ambitious, cross-sectoral endeavor that aims to lay out a citizens’ roadmap to achieving universal health coverage for the people of India. Our new webinar series is intended to serve as a platform for public health discourse in India, and a means for academics, practitioners and the public to engage on substantive and timely issues regarding universal health coverage in India.
TheLancet COVID-19 Commission is an interdisciplinary initiative across the health sciences, business, finance, and public policy that was launched in July 2020. It has four themes: to propose recommendations on how best to suppress the epidemic; to address the humanitarian crises arising from the pandemic; addressing the financial and economic crises resulting from the pandemic; and rebuilding an inclusive, fair, and sustainable world. The work of the Commission is supported by twelve Task Forces, in areas ranging from vaccine development, to humanitarian relief strategies, to safe workplaces, to global economic recovery. The India Task Force of the COVID-19 Commission is the only country-specific Task Force, set up in recognition of the unique challenges that India faces in the context of COVID-19.
The first webinar in the series is a joint event with the Lancet COVID-19 Commission India Task Force and will be a panel discussion about the devastating COVID-19 pandemic surge in India – focusing on the short and long-term actions that are needed to address the impact. Leading experts from the medical, scientific, and public policy community will discuss the lessons that need to be learnt and propose what the next steps should be to respond to, and improve, the situation in India. As a Citizens’ Commission, we invite the public to participate in the discussion, provide input and engage with the panelists.
Over the past three years, the Mittal Institute, in partnership with the Tata Trusts, has been conducting research into innovations in healthcare in India. These innovations are focused on expanding access to care, widening the range of services offered, and re-imagining the mode of healthcare delivery. Join us for a discussion on this research. Panelists will speak about innovating in the public health sector, translating health research into practice, and the challenges of creating an enabling environment for these innovations to thrive.
Welcome Remarks by Manoj Kumar, Founder, Social Alpha and Senior Advisor, Tata Trusts
Moderator:
Vikram Patel, The Pershing Square Professor of Global Health, Harvard Medical School
Panelists:
Satchit Balsari, Assistant Professor in Emergency Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center
Anant Bhan, Bhopal Hub Head, Sangath
Pawan Sinha, Professor of Vision and Computational Neuroscience, Massachusetts Institute of Technology
Rajani Ved, Former Executive Director, National Health Systems Resource Centre
Arthur Kleinman, Professor of Medical Anthropology, Department of Global Health and Social Medicine, Harvard Medical School
Panelists
Xiao Shuiyuan, Professor, Central South University, Xianya School of Public Health
Yifeng Xu, President, Shanghai Mental Health Center; Head & Professor, Department of Psychiatry, Shanghai Jiao Tong University School of Medicine; Director, WHO/Shanghai Collaborating Center for Research and Training in Mental Health
Vikram Patel, The Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow, Department of Global Health and Social Medicine, Harvard Medical School; Professor, Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Co-Founder and Member of Managing Committee, Sangath
Karestan Koenen, Professor of Psychiatric Epidemiology, Department of Epidemiology and Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health
Host and Commentator
Winnie Yip, Professor of Global Health Policy and Economics, Harvard T.H. Chan School of Public Health; Director, Harvard China Health Partnership; Acting Director, Fairbank Center for Chinese Studies
This is a Fairbank Center Director’s Seminar. This event is sponsored by the Fairbank Center for Chinese Studies and the Harvard China Health Partnership, and co-sponsored by the Lakshmi Mittal and Family South Asia Institute.
COVID-19 has claimed many lives in the world. It has also caused catastrophic economic, social, and psychological costs that have far-reaching implications on human welfare. This session examines the effects of COVID-19 on the economy of China, the first country hit by COVID-19 and the first major economy that is gradually re-opening.
Panelists: Hongqiao Fu, Assistant Professor in Health Economics and Policy in School of Public Health, Peking University Ajay Nair, Co-founder, MeraDoctor Atveev Mehrotra, Associate Professor of Health Care Policy, Harvard Medical School
Moderator: Winnie Chi-Man Yip, Professor of Global Health Policy and Economics, Harvard School of Public Health; Director, Harvard China Health Partnership; Interim Director, Fairbank Center for Chinese Studies.
Sponsored by Fairbank Center for Chinese Studies and Harvard China Health Partnership. Co-sponsored by the Lakshmi Mittal and Family South Asia Institute and the Harvard University Asia Center. This panel discussion is presented as part of “24 Hours of Harvard,” a special feature of Worldwide Week at Harvard 2020.
This discussion will be streamed online. Check back soon for viewing information.
Tarun Khanna, Jorge Paulo Lemann Professor, Harvard Business School & Director, Lakshmi Mittal and Family South Asia Institute, Harvard University
Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations
Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd.
David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health
Through the lens of a contemporary case study, Harvard Business School Professor Tarun Khanna will share the geo-politics of how vaccines are developed, the funding and distribution methods that are critical to the effort, and the global alliances that facilitate this in the world today. He will speak with Dr. Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations; Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd, and Dr. David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health, in a discussion on the South Asia context.
The objective is to share the mechanics and commerce of vaccine development and the critical role that science and business can play in combating pandemics such as COVID-19. The intent is to foster a collaborative and synchronous effort among science, business, and government to find synergies and solutions as they navigate the current challenges. How does one forge worldwide alliances in healthcare? How can science, business, government, and society collaborate on healthcare imperatives? How does one resolve the logistics and equity of vaccine distribution, and how can credibility and trust be built? This interactive conversation will be presented via Zoom web-conference.
Purnima Menon, Senior Research Fellow, Poverty, Health, and Nutrition Division, International Food Policy Research Institute
Poonam Muttreja, Executive Director, Population Foundation of India
Vikram Patel, Pershing Square Professor of Global Health, Harvard Medical School
Discussant
Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine, Harvard Medical School; Co-Founder and Chief Strategist, Partners In Health
“Outbreak: Epidemics in a Connected World”, an event jointly organized by The Lakshmi Mittal and Family South Asia Institute and the Harvard Global Health Institute and presented in New Delhi, examined the connections between human, animal and environmental health, and the response to disease outbreaks in India.
Location: Kresge G3, HSPH, 677 Huntington Avenue, Boston, MA
Rajani R. Ved is the Executive Director of National Health Systems Resource Centre in India’s Ministry of Health and Family Welfare and a Visiting Scientist at HSPH. For over ten years, she led the establishment and institutionalization of India’s ASHA community health worker program. Currently, she is leading the design and implementation support for India’s primary health care initiative, Ayushman Bharat Health and Wellness Centers.
Speaker: Dr. Rajani R. Ved, Executive Director, National Health Systems Resource Center, Ministry of Health and Family Welfare, Government of India
Moderator: Bhargav Krishna, Doctoral Candidate in Public Health, Harvard T.H. Chan School of Public Health; Adjunct Faculty, Public Health Foundation of India
This event is co-sponsored with the South Asian Students Association at Harvard T.H. Chan School of Public Health.
Join us for our ongoing India Seminar Series to discuss the growing challenge of Water Fluorosis, in a discussion titled, ‘Tackling Fluorosis: Innovative technology as a solution to the spreading health crisis’
There are about 66 million people in India suffering from toxic levels of fluoride in their drinking water, these are mostly poor people in rural communities in dry / arid area that must depend of groundwater as their drinking water source. Fluoride is a vicious toxic ion in the sense that it affects and attacks the poor far more aggressively that it affects those nutritionally better off. It also is very effective in ruining the lives of very young people who then suffer from serious bone deformation (skeletal fluorosis) and its harmful economic, social, and psychological effects.
The panelists for this discussion include,
– Dr. Andrew Z. Haddad- ITRI-Rosenfeld Postdoctoral Fellow, Lawrence Berkeley National Lab
– Srikrishna Sridhar Murthy- Founder and CEO, Sattva Consulting
– Dr. Sunderrajan Krishnan- Executive Director, INREM Foundation
Ramanan Laxminarayan, Vice President for Research and Policy at the Public Health Foundation of India; Director, Center for Disease Dynamics, Economics & Policy in Washington DC; Research Scholar and Lecturer at Princeton University
Professor Laxminarayan is Vice President for Research and Policy at the Public Health Foundation of India. He is an economist and epidemiologist by training. His research work deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems.
Prof Laxminarayan also directs the Center for Disease Dynamics, Economics & Policy in Washington DC, and is a Research Scholar and Lecturer at Princeton University.
Co-sponsored with the India Health Partnership in the Department of Global Health and Population, and the Harvard Global Health Institute
Omar Ishrak, Chairman and Chief Executive Officer, Medtronic
Discussant: Conor Walsh,Assistant Professor of Mechanical and Biomedical Engineering, Harvard School of Engineering and Applied Sciences
Chair: Tarun Khanna, Director, Harvard South Asia Institute,Jorge Paulo LemannProfessor, Harvard Business School
Over the last several decades, medical technology advancements have steadily improved the standard of care for patients in many areas of the world. At the same time, a huge disparity in access to high quality, cost-effective healthcare continues to exist for billions of people. The need in South Asia is particularly acute, with access to care limited to less than 10% of an estimated population of nearly 2 billion people. Innovation must address significant barriers, including a lack of patient awareness, infrastructure and training for healthcare professionals. Medtronic has started a unique program in India using a new business model to target a specific disease, define the full care continuum and build an ecosystem approach to address populations with little to no access to care. Addressing this huge challenge – and opportunity – requires a coordinated effort across multiple stakeholders to deliver innovation to improve outcomes, expand access and increase affordability of healthcare in South Asia.
Thomas Vallely, Senior Advisor, Mainland Southeast Asia, Ash Center, Harvard Kennedy School
Dr. Cynthia Maung, Director, Mae Tao Clinic, Thai-Burmese Border
Dr. Parveen K. Parmar, Harvard Humanitarian Initiative, Community Partners International
Phyu Phyu Saan, Senior Researcher, Global Justice Center, New York
Chair: Arthur Kleinman, Director, Harvard University Asia Center; Esther and Sidney Rabb Professor of Anthropology, Harvard University; Professor of Medical Anthropology and Professor of Psychiatry, Harvard Medical School
